A Case of Unusual Umbilical Lichen Planus Associated with Pembrolizumab

at 3.1 on VAS, higher if still on ICI (4.8 vs 2.7, p<0.01), and in G3 (4.2 vs 2.9 and 1.2, p<0.0001).Out of them, 64.9% discussed QoL topics with healthcare professionals (HP), but 22.8% could not express them as they wished (Fig1).Improvement of QoL management should primarily be based on enhanced adverse event monitoring and better HP training (Fig2).Conclusions: While most ICI-DR patients reported satisfactory QoL, a proportion with moderate problems across EQ5D-5L dimensions faced daily life issues.One in five patients felt unable to adequately discuss their QoL concerns with HP.Patient-prioritized measures could improve the situation.